Showing 1241-1250 of 8226 results for "".
Assessing the CapsuLaser for Primary Posterior Capsulotomy
https://crstoday.com/topics/cataract-surgery/assessing-the-capsulaser-for-primary-posterior-capsulotomy/43875/This device can create capsular openings of consistent size.Under Investigation: Accelerated CXL
https://crstoday.com/topics/general/under-investigation-accelerated-cxl/43323/Not Just Another Pilocarpine
https://crstoday.com/crst-supplements/not-just-another-pilocarpine/not-just-another-pilocarpine/45482/An in-depth look at the new Qlosi™ topical drop for presbyopia.US Ophthalmologists' Wish Lists
https://crstoday.com/topics/general/us-ophthalmologists-wish-lists/42563/Products surgeons wanted to bring home from the ESCRS meeting.Eye Care for the Millennium Villages
https://crstoday.com/topics/general/crst0408_05-php/41469/Outreach efforts in Africa seek to mitigate the economic impact of blindness.Veterans Remember: The Great Ophthalmological War and the Rise of the ASCRS
https://crstoday.com/topics/general/veterans-remember-the-great-ophthalmological-war-and-the-rise-of-the-ascrs/41785/The paradigm shift that shook cataract and refractive surgery.Preventing Complications in Eyes With Pseudoexfoliation
https://crstoday.com/topics/general/focus-on-eyes-with-zonular-weakness-preventing-complications-in-eyes-with-pseudoexfoliation/41828/How to prepare and deal with these complicated cataracts.Update on Accommodating IOLs
https://crstoday.com/crst-issues/aug-2024/update-on-accommodating-iols/45349/Exploring the latest advances in adaptive and shape-changing IOL technology.Endoscopic Cyclophotocoagulation and Its Indications in Glaucoma Therapy
https://crstoday.com/topics/general/endoscopic-cyclophotocoagulation-and-its-indications-in-glaucoma-therapy/41778/A versatile treatment option.Beyond DEWS II
https://crstoday.com/crst-issues/apr-2024/beyond-dews-ii/45268/An overview of the latest advances in dry eye disease management, treatment innovations, and insights into the condition’s pathophysiology since the landmark TFOS DEWS II report.